Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL MRI CONTRAST MEDIA MARKET SIZE IS EXPECTED TO REACH USD 1.97 BILLION BY 2029 FROM USD 1.45 BILLION IN 2023, GROWING AT A CAGR OF 5.20% DURING THE FORECAST PERIOD.
The Global MRI Contrast Media Market Size, Share, & Trends Analysis Report By
- Product Type: Paramagnetic and Superparamagnetic
- Application: Cancer, Cardiovascular Disorders, Neurological Disorders, Gastrointestinal Disorders, and Others
- Route of Administration: Intravenous, Oral, and Others
- End-user: Standalone Imaging Centers and Hospitals
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL MRI CONTRAST MEDIA MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2029) | USD 1.97 Billion |
| Market Size (2023) | USD 1.45 Billion |
| CAGR (2023-2029) | 5.20% |
| HISTORIC YEAR | 2020-2022 |
| BASE YEAR | 2023 |
| FORECAST YEAR | 2024-2029 |
| SEGMENTS BY | Product Type, Application, Route of Administration, End-user, and Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | Bayer, Bracco, GE Healthcare, and Guerbet |
MARKET INSIGHTS
The global MRI contrast media market was valued at USD 1.45 billion in 2023 and is expected to reach USD 1.97 billion by 2029, growing at a CAGR of 5.20% during the forecast period. The global Magnetic Resonance Imaging (MRI) contrast media market has undergone significant transformation in recent years, propelled by technological advancements, increasing prevalence of chronic diseases, and a growing demand for more accurate diagnostic tools. MRI contrast media, also known as contrast agents, play a pivotal role in enhancing the visibility of specific tissues during imaging procedures.
The MRI contrast media market is dynamic and competitive, marked by several key players vying for market share. Companies such as Bayer, Bracco, GE Healthcare, and Guerbet are among the leading contributors to the global market. These entities are characterized by their commitment to research and development, strategic collaborations, and a focus on introducing innovative contrast agents to meet the evolving needs of healthcare professionals. Furthermore, advances in MRI technology continue to drive the demand for novel and improved contrast agents. Companies investing in research and development to create agents with enhanced safety profiles and diagnostic efficacy gain a competitive edge. The rising prevalence of chronic diseases, such as cardiovascular disorders and cancers, has led to an increased reliance on diagnostic imaging techniques like MRI. This, in turn, fuels the demand for contrast media for more accurate and early detection of abnormalities.
Stringent regulatory requirements for the approval and marketing of MRI contrast agents pose a challenge to companies in the market. Adhering to complex regulatory processes is crucial for ensuring the safety and efficacy of these agents. Some gadolinium-based contrast agents have been associated with concerns related to gadolinium retention in certain tissues, raising questions about their long-term safety. This has prompted the exploration of alternative contrast agents and gadolinium-free formulations. Economic conditions, healthcare spending, and reimbursement policies in different regions impact the market dynamics. Companies adapting to these economic variables can position themselves effectively in various markets.
Furthermore, the ongoing research focuses on developing gadolinium-free contrast agents to address safety concerns. Substances such as manganese and iron are being explored for their potential as alternatives. Incorporating AI in medical imaging, including MRI, is expected to play a significant role. Smart contrast agents interacting with AI algorithms for real-time image analysis and interpretation may become a trend.
The MRI contrast media market is poised for continued growth and innovation as it responds to the evolving landscape of healthcare and diagnostic imaging. The interplay of technological advancements, strategic collaborations, and a commitment to addressing safety concerns will shape the future of this market. As the industry progresses, companies that navigate regulatory challenges, embrace emerging trends, and prioritize patient safety will likely thrive in this competitive and dynamic market.
MARKET TRENDS & DRIVERS
Emerging Biomedical Imaging-based Companion Diagnostics for Precision Oncology
The symbiotic relationship between emerging biomedical imaging-based companion diagnostics and the MRI contrast media market in precision oncology presents a captivating tale of progress. By tackling the existing challenges and seizing the vast opportunities, this dynamic duo has the potential to revolutionize cancer diagnosis and treatment, ushering in a future where personalized medicine reigns supreme, offering hope and improved outcomes for patients battling this formidable disease. The future of this landscape is not merely a market growth story; it is a testament to human ingenuity and unwavering pursuit of a healthier tomorrow, written in the vivid language of image and precision.
Rising Cancer Prevalence
The symbiotic relationship between the rising cancer prevalence and the global MRI contrast media market holds immense promise for the future of cancer care. Advances in contrast agent development, coupled with improved accessibility and streamlined regulatory pathways, can empower physicians with a powerful tool for earlier, more accurate diagnoses and personalized treatment plans. The rising cancer prevalence directly impacts the MRI contrast media industry, fueling its growth and driving innovation. MRI, a non-invasive imaging technique that uses powerful magnets and radio waves to generate detailed images of the body's internal structures, has proven instrumental in cancer diagnosis. Its ability to provide high-resolution, multi-dimensional images makes it particularly valuable for detecting and characterizing various cancers, including the brain, breast, prostate, and liver.
Increasing Demand for Diagnostic Imaging
Diagnostic imaging has become an indispensable tool in modern healthcare, enabling clinicians to visualize and analyze internal structures for accurate diagnosis and treatment planning. Among the various imaging modalities, Magnetic Resonance Imaging (MRI) stands out for its exceptional ability to provide detailed, high-resolution images without exposing patients to ionizing radiation. The increasing demand for diagnostic imaging, particularly MRI, is a key driver propelling the growth of the MRI contrast media market. Also, the global prevalence of chronic diseases, such as cardiovascular conditions, neurological disorders, and various types of cancers, has been steadily rising. The need for accurate and early diagnosis is paramount for effective disease management. With its superior soft tissue contrast and multi-planar imaging capabilities, MRI has emerged as a preferred modality for diagnosing and monitoring these conditions. As the prevalence of diseases continues to increase, so does the demand for diagnostic imaging, driving the adoption of MRI contrast media.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT TYPE
The paramagnetic product type dominated the global MRI contrast media market share in 2023. Paramagnetic contrast agents contain paramagnetic ions, typically gadolinium, which enhance MRI signal intensity, improving image contrast and visualization of anatomical structures. Furthermore, superparamagnetic contrast agents, such as iron oxide nanoparticles, exhibit superparamagnetic behavior, enhancing MRI signal in T2-weighted images and enabling targeted imaging of specific tissues or pathologies. These distinct product types cater to diverse clinical needs and imaging requirements, contributing to the overall growth and evolution of the global MRI contrast media market.
INSIGHTS BY APPLICATION
The global MRI contrast media market by application is segmented as cancer, cardiovascular disorders, neurological disorders, gastrointestinal disorders, and others. MRI contrast media are widely used in oncology for detecting, staging, and monitoring various types of cancers, including breast, prostate, lung, and brain tumors. In 2023, the cancer application segment held the largest global MRI contrast media market share. Further, contrast-enhanced MRI scans help oncologists visualize tumor characteristics, assess treatment response, and guide therapeutic interventions. MRI contrast media play a crucial role in cardiovascular imaging, enabling the visualization of cardiac anatomy, function, and blood flow. Contrast-enhanced MRI scans are used to diagnose and assess a wide range of cardiovascular conditions, such as myocardial infarction, heart failure, congenital heart defects, and vascular abnormalities.
MRI contrast media are essential for diagnosing and monitoring neurological disorders affecting the brain, spinal cord, and peripheral nerves. Contrast-enhanced MRI scans help neurologists evaluate conditions such as brain tumors, multiple sclerosis, stroke, neurodegenerative diseases, and spinal cord injuries, providing valuable insights into disease progression and treatment response. MRI contrast media are utilized in gastrointestinal imaging to evaluate the structure and function of the digestive system. Contrast-enhanced MRI scans aid gastroenterologists in diagnosing and monitoring conditions such as liver cirrhosis, hepatocellular carcinoma, pancreatic tumors, inflammatory bowel disease, and gastrointestinal bleeding, facilitating timely intervention and management.
In addition to the abovementioned applications, MRI contrast media are useful in various medical specialties and conditions, including musculoskeletal imaging, renal diseases, urological disorders, gynecological conditions, and pediatric imaging. These contrast agents enable healthcare providers to obtain detailed anatomical and functional information for accurate diagnosis, treatment planning, and patient management across various medical disciplines.
INSIGHTS BY ROUTE OF ADMINISTRATION
The global MRI contrast media market by route of administration is segmented into intravenous, oral, and other categories. Intravenous administration remains dominant due to its widespread use and efficacy in enhancing imaging contrast. Oral contrast agents are utilized for specific gastrointestinal imaging studies, while rectal is primarily employed for pelvic and rectal MRI examinations. The market's growth is driven by technological advancements, expanding applications of MRI imaging, and increasing demand for personalized diagnostic solutions.
INSIGHTS BY END-USER
The standalone imaging centers end-user segment holds the most prominent share of the global MRI contrast media market. Standalone diagnostic imaging centers focus solely on providing imaging services to patients. These centers offer a convenient and efficient alternative to hospitals for diagnostic imaging procedures, including MRI scans. Diagnostic imaging centers serve as significant end-users of MRI contrast media, performing many MRI examinations for patients across various medical specialties. Further, hospitals are major end-users of MRI contrast media, providing comprehensive healthcare services, including diagnostic imaging. Hospitals utilize MRI contrast media for a wide range of diagnostic procedures, from routine scans to complex imaging studies, to aid in accurately diagnosing and treating various medical conditions.
GEOGRAPHICAL ANALYSIS
The global MRI contrast media market is geographically diverse, with significant market presence across various regions worldwide. At the same time, the market landscape may fluctuate due to factors such as regulatory environment, healthcare infrastructure, and economic conditions. North America, particularly the U.S., represents one of the largest global markets for MRI contrast media. Factors such as advanced healthcare infrastructure, high prevalence of chronic diseases, and widespread adoption of medical imaging technologies drive market growth in this region. Europe is another major MRI contrast media v, with countries like Germany, the U.K., and France leading in market share. The presence of well-established healthcare systems, growing aging population, and increasing demand for advanced diagnostic imaging contribute to market expansion in Europe.
APAC region is experiencing rapid growth in the MRI contrast media industry and is projected to witness the fastest CAGR during the forecast period, driven by rising healthcare expenditure, expanding medical tourism industry, and increasing awareness about preventive healthcare. Countries such as China, Japan, and India are key contributors to market growth in this region. Latin America is emerging as a promising MRI contrast media market, fueled by improving healthcare infrastructure, growing healthcare spending, and rising prevalence of chronic diseases. Countries such as Brazil, Mexico, and Argentina offer significant growth opportunities for market players. The Middle East & Africa region is witnessing steady growth in the MRI contrast media industry, supported by government initiatives to enhance healthcare infrastructure, increasing investments in medical imaging technologies, and the rising prevalence of chronic diseases. Countries such as Turkey, South Africa, Saudi Arabia, and UAE are key markets in the region.
VENDOR LANDSCAPE
Medical imaging plays a crucial role in diagnosing and monitoring various health conditions, and Magnetic Resonance Imaging (MRI) is a key technology in this field. MRI contrast media, also known as contrast agents, enhance the visibility of specific structures or abnormalities during imaging procedures. The global MRI contrast media market has witnessed significant growth in recent years, driven by advancements in medical imaging technology, an aging population, and an increasing prevalence of chronic diseases.
The global MRI contrast media market is influenced by various factors that shape its dynamics. Continuous advancements in MRI technology drive the development of new and improved contrast agents. Companies that invest in research and development to create cutting-edge products gain a competitive edge in the MRI contrast media industry. Stringent regulatory requirements for the approval and marketing of MRI contrast agents impact the market. Companies with a robust understanding of regulatory processes and compliance have a competitive advantage.
Bayer is a leading pharmaceutical and life sciences company with a strong presence in the MRI contrast media industry. The company's commitment to innovation and research has allowed it to develop and market a range of contrast agents for various MRI applications. As a global conglomerate, GE Healthcare has a significant presence in the healthcare sector, including medical imaging. GE Healthcare offers a variety of MRI contrast agents, contributing to its competitiveness in the market.
Frequently Asked Questions
Which region dominates the global MRI contrast media market share?
What are the significant trends in the MRI contrast media industry?
What is the growth rate of the global MRI contrast media market?
How big is the MRI contrast media market?
Who are the key players in the global MRI contrast media market?
The global MRI contrast media market size is expected to grow at a CAGR of approximately 5.20% from 2023 to 2029.
The following factors are likely to contribute to the growth of the global MRI contrast media market during the forecast period:
- Rising Cancer Prevalence
- Technological Advancements in MRI Technology
- Increasing Demand for Diagnostic Imaging
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the global MRI contrast media market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- Bayer
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- Bracco
- GE Healthcare
- Guerbet
Other Prominent Vendors
- Imagion Biosystems
- Business Overview
- Product Offerings
- iMAX
- Jodas Expoim
- Lantheus Holdings
- Miltenyi Biotec
- Reveal Pharmaceuticals
- Spago Nanomedical AB
- TAEJOON PHARM
- VitalQuan
Segmentation by Product Type
- Paramagnetic
- Superparamagnetic
Segmentation by Application
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Others
Segmentation by Route of Administration
- Intravenous
- Oral
- Others
Segmentation by End-user
- Standalone Imaging Centers
- Hospitals
Segmentation by Geography
- North AmericaThe U.S.
- Canada
- EuropeGermany
- France
- The U.K.
- Italy
- Spain
- Russia
- Netherlands
- APACChina
- Japan
- India
- South Korea
- Australia
- Latin AmericaBrazil
- Mexico
- Argentina
- Colombia
- Middle East & AfricaTurkey
- Saudi Arabia
- South Africa
- UAE
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 GLOBAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 3 GLOBAL MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 4 GLOBAL MRI CONTRAST MEDIA MARKET BY APPLICATION: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 5 GLOBAL MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 6 GLOBAL MRI CONTRAST MEDIA MARKET BY END-USER: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 7 IMPACT OF INCREASING APPLICATIONS OF MRI CONTRAST MEDIA IN NON-CANCER CONDITIONS
EXHIBIT 8 IMPACT OF ADVANCED RESEARCH ON MRI CONTRAST MEDIA
EXHIBIT 9 IMPACT OF EMERGING BIOMEDICAL IMAGING-BASED COMPANION DIAGNOSTICS FOR PRECISION ONCOLOGY
EXHIBIT 10 IMPACT OF GROWING PREVALENCE OF CANCERS
EXHIBIT 11 IMPACT OF ADVANCES IN MRI TECHNOLOGY
EXHIBIT 12 IMPACT OF INCREASING DEMAND FOR DIAGNOSTIC IMAGING
EXHIBIT 13 IMPACT OF SIDE-EFFECTS AND ALLERGIC REACTIONS ASSOCIATED WITH MRI CONTRAST MEDIA
EXHIBIT 14 IMPACT OF AVAILABILITY OF ALTERNATIVE IMAGING MODALITIES
EXHIBIT 15 IMPACT OF CONCERNS OVER MRI GADOLINIUM RETENTION IN BRAIN
EXHIBIT 16 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 17 FIVE FORCES ANALYSIS 2023
EXHIBIT 18 INCREMENTAL GROWTH BY PRODUCT TYPE 2023 & 2029
EXHIBIT 19 GLOBAL MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023–2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 20 GLOBAL MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 21 GLOBAL PARAMAGNETIC MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 22 GLOBAL PARAMAGNETIC MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 23 GLOBAL SUPERPARAMAGNETIC MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 24 GLOBAL SUPERPARAMAGNETIC MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 25 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
EXHIBIT 26 GLOBAL MRI CONTRAST MEDIA MARKET BY APPLICATION 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 27 GLOBAL MRI CONTRAST MEDIA MARKET BY APPLICATION 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 28 GLOBAL CANCER MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL CANCER MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 30 GLOBAL CARDIOVASCULAR DISEASES MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL CARDIOVASCULAR DISEASES MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 32 GLOBAL NEUROLOGICAL DISORDERS MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL NEUROLOGICAL DISORDERS MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 34 GLOBAL GASTROINTESTINAL DISORDERS MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL GASTROINTESTINAL DISORDERS MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 36 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 38 INCREMENTAL GROWTH BY ROUTE OF ADMINISTRATION 2023 & 2029
EXHIBIT 39 GLOBAL MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 40 GLOBAL MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 41 GLOBAL INTRAVENOUS MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL INTRAVENOUS MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 43 GLOBAL ORAL MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL ORAL MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 45 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 48 GLOBAL MRI CONTRAST MEDIA MARKET BY END-USER 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 49 GLOBAL MRI CONTRAST MEDIA MARKET BY END-USER 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 50 GLOBAL STANDALONE IMAGING CENTERS MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL STANDALONE IMAGING CENTERS MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 52 GLOBAL HOSPITALS MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 53 GLOBAL HOSPITALS MRI CONTRAST MEDIA MARKET 2023–2029 ($ MILLION)
EXHIBIT 54 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 55 GLOBAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 56 GLOBAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 57 NORTH AMERICA MRI CONTRAST MEDIA MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 58 NORTH AMERICA MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 NORTH AMERICA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 60 INCREMENTAL GROWTH IN NORTH AMERICA (2023 & 2029)
EXHIBIT 61 US MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 62 CANADA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 63 EUROPE MRI CONTRAST MEDIA MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 64 EUROPE MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 EUROPE MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 66 INCREMENTAL GROWTH IN EUROPE (2023 & 2029)
EXHIBIT 67 GERMANY MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 68 FRANCE MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 69 UK MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 70 ITALY MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 71 SPAIN MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 72 RUSSIA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 73 NETHERLANDS MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 74 APAC MRI CONTRAST MEDIA MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 75 APAC MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 APAC MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 77 INCREMENTAL GROWTH IN APAC (2023 & 2029)
EXHIBIT 78 CHINA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 79 JAPAN MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 80 INDIA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 81 SOUTH KOREA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 82 AUSTRALIA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 83 LATIN AMERICA MRI CONTRAST MEDIA MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 84 LATIN AMERICA MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 85 LATIN AMERICA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 86 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 87 BRAZIL MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 88 MEXICO MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 89 ARGENTINA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 90 COLOMBIA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 91 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 92 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 93 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 94 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA (2023 & 2029)
EXHIBIT 95 TURKEY MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 96 SOUTH AFRICA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 97 SAUDI ARABIA MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 98 UAE MRI CONTRAST MEDIA MARKET 2020–2029 ($ MILLION)
EXHIBIT 99 VENDORS OFFERING MRI CONTRAST MEDIA PRODUCTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 100 VENDORS OFFERING MRI CONTRAST MEDIA PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 101 KEY CAVEATS
LIST OF TABLES
TABLE 1 GLOBAL PARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 2 GLOBAL PARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 3 GLOBAL SUPERPARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 4 GLOBAL SUPERPARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 5 GLOBAL CANCER MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 6 GLOBAL CANCER MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 7 GLOBAL CARDIOVASCULAR DISEASES MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 8 GLOBAL CARDIOVASCULAR DISEASES MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 9 GLOBAL NEUROLOGICAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 10 GLOBAL NEUROLOGICAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 11 GLOBAL GASTROINTESTINAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 12 GLOBAL GASTROINTESTINAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 13 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 14 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 15 GLOBAL INTRAVENOUS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 16 GLOBAL INTRAVENOUS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 17 GLOBAL ORAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 18 GLOBAL ORAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 19 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 20 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 21 GLOBAL STANDALONE IMAGING CENTERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 22 GLOBAL STANDALONE IMAGING CENTERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 23 GLOBAL HOSPITALS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 24 GLOBAL HOSPITALS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 25 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 26 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 27 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 28 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 29 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 30 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 31 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 32 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 33 EUROPE MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 34 EUROPE MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 35 EUROPE MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 36 EUROPE MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 37 EUROPE MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 38 EUROPE MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 39 EUROPE MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 40 EUROPE MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 41 APAC MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 42 APAC MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 43 APAC MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 44 APAC MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 45 APAC MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 46 APAC MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 47 APAC MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 48 APAC MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 49 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 50 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 51 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 52 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 53 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 54 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 55 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 56 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 57 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 58 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 59 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 60 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 61 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 62 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 63 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 64 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 65 BAYER: MAJOR PRODUCT OFFERINGS
TABLE 66 BRACCO: MAJOR PRODUCT OFFERINGS
TABLE 67 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 68 GUERBET: MAJOR PRODUCT OFFERINGS
TABLE 69 IMAGION BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 70 IMAX: MAJOR PRODUCT OFFERINGS
TABLE 71 JODAS EXPOIM: MAJOR PRODUCT OFFERINGS
TABLE 72 LANTHEUS HOLDINGS: MAJOR PRODUCT OFFERINGS
TABLE 73 MILTENYI BIOTEC: MAJOR PRODUCT OFFERINGS
TABLE 74 REVEAL PHARMACEUTICALS: MAJOR PRODUCT OFFERINGS
TABLE 75 SPAGO NANOMEDICAL AB: MAJOR PRODUCT OFFERINGS
TABLE 76 TAEJOON PHARM: MAJOR PRODUCT OFFERINGS
TABLE 77 VITALQUAN: MAJOR PRODUCT OFFERINGS
TABLE 78 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 79 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 80 EUROPE MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 81 EUROPE MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 82 APAC MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 83 APAC MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 84 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 85 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 86 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 87 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 88 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 89 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 90 EUROPE MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 91 EUROPE MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 92 APAC MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 93 APAC MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 94 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 95 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 96 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 97 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY APPLICATION 2023−2029 (%)
TABLE 98 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 99 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 100 EUROPE MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 101 EUROPE MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 102 APAC MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 103 APAC MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 104 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 105 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 106 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 ($ MILLION)
TABLE 107 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY ROUTE OF ADMINISTRATION 2023−2029 (%)
TABLE 108 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 109 NORTH AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 110 EUROPE MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 111 EUROPE MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 112 APAC MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 113 APAC MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 114 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 115 LATIN AMERICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 116 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 117 MIDDLE EAST & AFRICA MRI CONTRAST MEDIA MARKET BY END-USER 2023−2029 (%)
TABLE 118 GLOBAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 119 GLOBAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 120 GLOBAL PARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 121 GLOBAL PARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 122 GLOBAL SUPERPARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 123 GLOBAL SUPERPARAMAGNETIC MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 124 GLOBAL CANCER MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 125 GLOBAL CANCER MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 126 GLOBAL CARDIOVASCULAR DISEASES MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 127 GLOBAL CARDIOVASCULAR DISEASES MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 128 GLOBAL NEUROLOGICAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 129 GLOBAL NEUROLOGICAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 130 GLOBAL GASTROINTESTINAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 131 GLOBAL GASTROINTESTINAL DISORDERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 132 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 133 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 134 GLOBAL INTRAVENOUS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 135 GLOBAL INTRAVENOUS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 136 GLOBAL ORAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 137 GLOBAL ORAL MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 138 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 139 GLOBAL OTHERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 140 GLOBAL STANDALONE IMAGING CENTERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 141 GLOBAL STANDALONE IMAGING CENTERS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 142 GLOBAL HOSPITALS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 143 GLOBAL HOSPITALS MRI CONTRAST MEDIA MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 144 CURRENCY CONVERSION 2016−2023
1. SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. MARKET SEGMENTATION & DEFINITION
1.2.1. PRODUCT TYPE
1.2.2. APPLICATION
1.2.3. ROUTE OF ADMINISTARTION
1.2.4. END-USER
1.2.5. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
BASE YEAR
2. PREMIUM INSIGHTS
2.1. OVERVIEW
2.2. OPPORTUNITY POCKETS
3. MARKET AT A GLANCE
4. INTRODUCTION
4.1. OVERVIEW
5. MARKET OPPORTUNITIES & TRENDS
5.1. INCREASING APPLICATIONS OF MRI CONTRAST MEDIA IN NON-CANCER CONDITIONS
5.2. ADVANCED RESEARCH ON MRI CONTRAST MEDIA
5.3. EMERGING BIOMEDICAL IMAGING-BASED COMPANION DIAGNOSTICS FOR PRECISION ONCOLOGY
6. MARKET GROWTH ENABLERS
6.1. GROWING PREVALENCE OF CANCERS
6.2. ADVANCES IN MRI TECHNOLOGY
6.3. INCREASING DEMAND FOR DIAGNOSTIC IMAGING
7. MARKET RESTRAINTS
7.1. SIDE-EFFECTS AND ALLERGIC REACTIONS ASSOCIATED WITH MRI CONTRAST MEDIA
7.2. AVAILABILITY OF ALTERNATIVE IMAGING MODALITIES
7.3. CONCERNS OVER MRI GADOLINIUM RETENTION IN BRAIN
8. MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9. PRODUCT TYPE
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. PARAMAGNETIC
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. PARAMAGNETIC MARKET BY GEOGRAPHY
9.4. SUPERPARAMAGNETIC
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. SUPERPARAMAGNETIC MARKET BY GEOGRAPHY
10. APPLICATION
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. CANCER
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. CANCER MARKET BY GEOGRAPHY
10.4. CARDIOVASCULAR DISEASES
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. CARDIOVASCULAR DISEASES MARKET BY GEOGRAPHY
10.5. NEUROLOGICAL DISORDERS
10.5.1. MARKET OVERVIEW
10.5.2. MARKET SIZE & FORECAST
10.5.3. NEUROLOGICAL DISORDERS MARKET BY GEOGRAPHY
10.6. GASTROINTESTINAL DISORDERS
10.6.1. MARKET OVERVIEW
10.6.2. MARKET SIZE & FORECAST
10.6.3. GASTROINTESTINAL DISORDERS MARKET BY GEOGRAPHY
10.7. OTHERS
10.7.1. MARKET OVERVIEW
10.7.2. MARKET SIZE & FORECAST
10.7.3. OTHERS MARKET BY GEOGRAPHY
11. ROUTE OF ADMINISTRATION
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. INTRAVENOUS
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. INTRAVENOUS MARKET BY GEOGRAPHY
11.4. ORAL
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. ORAL MARKET BY GEOGRAPHY
11.5. OTHERS
11.5.1. MARKET OVERVIEW
11.5.2. MARKET SIZE & FORECAST
11.5.3. OTHERS MARKET BY GEOGRAPHY
12. END-USER
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. MARKET OVERVIEW
12.3. STANDALONE IMAGING CENTERS
12.3.1. MARKET OVERVIEW
12.3.2. MARKET SIZE & FORECAST
12.3.3. STANDALONE IMAGING CENTERS MARKET BY GEOGRAPHY
12.4. HOSPITALS
12.4.1. MARKET OVERVIEW
12.4.2. MARKET SIZE & FORECAST
12.4.3. HOSPITALS MARKET BY GEOGRAPHY
13. GEOGRAPHY
13.1. MARKET SNAPSHOT & GROWTH ENGINE
13.2. GEOGRAPHIC OVERVIEW
14. NORTH AMERICA
14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.2.1. NORTH AMERICA MARKET BY PRODUCT TYPE
14.2.2. NORTH AMERICA MARKET BY APPLICATION
14.2.3. NORTH AMERICA MARKET BY ROUTE OF ADMINISTRATION
14.2.4. NORTH AMERICA MARKET BY END-USER
14.3. KEY COUNTRIES
14.3.1. US: MARKET SIZE & FORECAST
14.3.2. CANADA: MARKET SIZE & FORECAST
15. EUROPE
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.2.1. EUROPE MARKET BY PRODUCT TYPE
15.2.2. EUROPE MARKET BY APPLICATION
15.2.3. EUROPE MARKET BY ROUTE OF ADMINISTRATION
15.2.4. EUROPE MARKET BY END-USER
13.1. KEY COUNTRIES
15.2.5. GERMANY: MARKET SIZE & FORECAST
15.2.6. FRANCE: MARKET SIZE & FORECAST
15.2.7. UK: MARKET SIZE & FORECAST
15.2.8. ITALY: MARKET SIZE & FORECAST
15.2.9. SPAIN: MARKET SIZE & FORECAST
15.2.10. RUSSIA: MARKET SIZE & FORECAST
15.2.11. NETHERLANDS: MARKET SIZE & FORECAST
16. APAC
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.2.1. APAC MARKET BY PRODUCT TYPE
16.2.2. APAC MARKET BY APPLICATION
16.2.3. APAC MARKET BY ROUTE OF ADMINISTRATION
16.2.4. APAC MARKET BY END-USER
16.3. KEY COUNTRIES
16.3.1. CHINA: MARKET SIZE & FORECAST
16.3.2. JAPAN: MARKET SIZE & FORECAST
16.3.3. INDIA: MARKET SIZE & FORECAST
16.3.4. SOUTH KOREA: MARKET SIZE & FORECAST
16.3.5. AUSTRALIA: MARKET SIZE & FORECAST
17. LATIN AMERICA
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.2.1. LATIN AMERICA MARKET BY PRODUCT TYPE
17.2.2. LATIN AMERICA MARKET BY APPLICATION
17.2.3. LATIN AMERICA MARKET BY ROUTE OF ADMINISTRATION
17.2.4. LATIN AMERICA MARKET BY END-USER
17.3. KEY COUNTRIES
17.3.1. BRAZIL: MARKET SIZE & FORECAST
17.3.2. MEXICO: MARKET SIZE & FORECAST
17.3.3. ARGENTINA: MARKET SIZE & FORECAST
17.3.4. COLOMBIA: MARKET SIZE & FORECAST
18. MIDDLE EAST & AFRICA
18.1. MARKET OVERVIEW
18.2. MARKET SIZE & FORECAST
18.2.1. MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
18.2.2. MIDDLE EAST & AFRICA MARKET BY APPLICATION
18.2.3. MIDDLE EAST & AFRICA MARKET BY ROUTE OF ADMINISTRATION
18.2.4. MIDDLE EAST & AFRICA MARKET BY END-USER
18.3. KEY COUNTRIES
18.3.1. TURKEY: MARKET SIZE & FORECAST
18.3.2. SOUTH AFRICA: MARKET SIZE & FORECAST
18.3.3. SAUDI ARABIA: MARKET SIZE & FORECAST
18.3.4. UAE: MARKET SIZE & FORECAST
19. COMPETITIVE LANDSCAPE
19.1. COMPETITION OVERVIEW
19.2. MARKET SHARE ANALYSIS
19.2.1. BAYER
19.2.2. BRACCO
19.2.3. GE HEALTHCARE
19.2.4. GURBET
20. KEY COMPANY PROFILES
20.1. BAYER
20.1.1. BUSINESS OVERVIEW
20.1.2. PRODUCT OFFERINGS
20.1.3. KEY STRATEGIES
20.1.4. KEY STRENGTHS
20.1.5. KEY OPPORTUNITIES
20.2. BRACCO
20.2.1. BUSINESS OVERVIEW
20.2.2. PRODUCT OFFERINGS
20.2.3. KEY STRATEGIES
20.2.4. KEY STRENGTHS
20.2.5. KEY OPPORTUNITIES
20.3. GE HEALTHCARE
20.3.1. BUSINESS OVERVIEW
20.3.2. PRODUCT OFFERINGS
20.3.3. KEY STRATEGIES
20.3.4. KEY STRENGTHS
20.3.5. KEY OPPORTUNITIES
20.4. GUERBET
20.4.1. BUSINESS OVERVIEW
20.4.2. PRODUCT OFFERINGS
20.4.3. KEY STRATEGIES
20.4.4. KEY STRENGTHS
20.4.5. KEY OPPORTUNITIES
21. OTHER PROMINENT VENDORS
21.1. IMAGION BIOSYSTEMS
21.1.1. BUSINESS OVERVIEW
21.1.2. PRODUCT OFFERINGS
21.2. IMAX
21.2.1. BUSINESS OVERVIEW
21.2.2. PRODUCT OFFERINGS
21.3. JODAS EXPOIM
21.3.1. BUSINESS OVERVIEW
21.3.2. PRODUCT OFFERINGS
21.4. LANTHEUS HOLDINGS
21.4.1. BUSINESS OVERVIEW
21.4.2. PRODUCT OFFERINGS
21.5. MILTENYI BIOTEC
21.5.1. BUSINESS OVERVIEW
21.5.2. PRODUCT OFFERINGS
21.6. REVEAL PHARMACEUTICALS
21.6.1. BUSINESS OVERVIEW
21.6.2. PRODUCT OFFERINGS
21.7. SPAGO NANOMEDICAL AB
21.7.1. BUSINESS OVERVIEW
21.7.2. PRODUCT OFFERINGS
21.8. TAEJOON PHARM
21.8.1. BUSINESS OVERVIEW
21.8.2. PRODUCT OFFERINGS
21.9. VITALQUAN
21.9.1. BUSINESS OVERVIEW
21.9.2. PRODUCT OFFERINGS
22. REPORT SUMMARY
22.1. KEY TAKEAWAYS
22.2. STRATEGIC RECOMMENDATIONS
23. QUANTITATIVE SUMMARY
21.1.1. NORTH AMERICA MARKET BY PRODUCT TYPE
21.1.2. EUROPE MARKET BY PRODUCT TYPE
21.1.3. APAC MARKET BY PRODUCT TYPE
21.1.4. LATIN AMERICA MARKET BY PRODUCT TYPE
21.1.5. MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
21.1.6. NORTH AMERICA MARKET BY APPLICATION
21.1.7. EUROPE MARKET BY APPLICATION
21.1.8. APAC MARKET BY APPLICATION
21.1.9. LATIN AMERICA MARKET BY APPLICATION
21.1.10. MIDDLE EAST & AFRICA MARKET BY APPLICATION
21.1.11. NORTH AMERICA MARKET BY ROUTE OF ADMINISTRATION
21.1.12. EUROPE MARKET BY ROUTE OF ADMINISTRATION
21.1.13. APAC MARKET BY ROUTE OF ADMINISTRATION
21.1.14. LATIN AMERICA MARKET BY ROUTE OF ADMINISTRATION
21.1.15. MIDDLE EAST & AFRICA MARKET BY ROUTE OF ADMINISTRATION
21.1.16. NORTH AMERICA MARKET BY END-USER
21.1.17. EUROPE MARKET BY END-USER
21.1.18. APAC MARKET BY END-USER
21.1.19. LATIN AMERICA MARKET BY END-USER
21.1.20. MIDDLE EAST & AFRICA MARKET BY END-USER
23.1. MARKET BY GEOGRAPHY
21.1.21. PARAMAGNETIC MARKET BY GEOGRAPHY
21.1.22. SUPERPARAMAGNETIC MARKET BY GEOGRAPHY
21.1.23. CANCER MARKET BY GEOGRAPHY
21.1.24. CARDIOVASCULAR DISEASES MARKET BY GEOGRAPHY
21.1.25. NEUROLOGICAL DISORDERS MARKET BY GEOGRAPHY
21.1.26. GASTROINTESTINAL DISORDERS MARKET BY GEOGRAPHY
21.1.27. OTHERS MARKET BY GEOGRAPHY
21.1.28. INTRAVENOUS MARKET BY GEOGRAPHY
21.1.29. ORAL MARKET BY GEOGRAPHY
21.1.30. OTHERS MARKET BY GEOGRAPHY
21.1.31. STANDALONE IMAGING CENTERS MARKET BY GEOGRAPHY
21.1.32. HOSPITALS MARKET BY GEOGRAPHY
24. APPENDIX
24.1. RESEARCH METHODOLOGY
24.2. RESEARCH PROCESS
24.3. REPORT ASSUMPTIONS & CAVEATS
24.3.1. KEY CAVEATS
24.3.2. CURRENCY CONVERSION
24.4. ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
Which region dominates the global MRI contrast media market share?
What are the significant trends in the MRI contrast media industry?
What is the growth rate of the global MRI contrast media market?
How big is the MRI contrast media market?
Who are the key players in the global MRI contrast media market?
other RELATED Reports
Mobile Medical Imaging Services Market - Global Outlook & Forecast 2022-2027
Published : July 2022
Live Cell Imaging Market – Global Outlook & Forecast Market 2022-2027
Published : September 2022
